How can we minimise the use of regular oral corticosteroids in asthma?

Options to achieve oral corticosteroid (OCS)-sparing have been triggering increasing interest since the 1970s because of the side-effects of OCSs, and this has now become achievable with biologics. The Société de Pneumologie de Langue Française workshop on OCSs aimed to conduct a comprehensive revie...

詳細記述

保存先:
書誌詳細
主要な著者: Arnaud Bourdin, Ian Adcock, Patrick Berger, Philippe Bonniaud, Philippe Chanson, Cécile Chenivesse, Jacques de Blic, Antoine Deschildre, Philippe Devillier, Gilles Devouassoux, Alain Didier, Gilles Garcia, Antoine Magnan, Yan Martinat, Thierry Perez, Nicolas Roche, Camille Taillé, Pierre Val, Pascal Chanez
フォーマット: Artigo
言語:Inglês
出版事項: European Respiratory Society 2020-02-01
シリーズ:European Respiratory Review
オンライン･アクセス:http://err.ersjournals.com/content/29/155/190085.full
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料